Prev：Engineering ferroptosis radiosensitizer for SPARC-targeted degradation: A strategy to reverse radioresistant non-small cell lung cancer(KTA0005-12.9)
Next：Enhanced CXCL10 expression in mast cells for cutaneous neurofibroma presenting with pain and itch.(BMS0050-6.8)
